F W Ruscetti - Concepedia

Author

F W Ruscetti

Frederick National Laboratory for Cancer Research

Also Known As

F Ruscetti, F W Ruscetti, F. Ruscetti, F. W. Ruscetti, F.W. Ruscetti, Francis W. Ruscetti

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Frederick National Laboratory for Cancer Research National Cancer Institute Genesis Laboratories National Cancer Institute University of Pittsburgh

About

F W Ruscetti is an author at Frederick National Laboratory for Cancer Research specializing in cell biology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.4K
2	Health Sciences	3	3	295
3	Engineering	1	1	13
4	Natural Sciences	1	1	10
5	Allergy	1	1	218

F W Ruscetti

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells Kjetil Hestdal, F W Ruscetti, James N. Ihle, The Journal of Immunology	1991	485
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. O Asai, Dan L. Longo, Zhihua Tian, Journal of Clinical Investigation Cell TherapyImmunologyNk CellsImmunotherapyNatural Killer Cells	1998	297
Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. Claire M. Dubois, F W Ruscetti, E W Palaszynski, The Journal of Experimental Medicine InflammationGrowth Factor ReceptorsCytokineIl-1 ActionIl-1r Expression	1990	221
Long-term culture of human antigen-specific cytotoxic T-cell lines. Steven Gillis, Paul E. Baker, F W Ruscetti, The Journal of Experimental Medicine Cell TherapyLong-term CultureAllergyT-regulatory CellImmunology	1978	218
Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J R Keller, Charlie Mantel, Garwin Sing, The Journal of Experimental Medicine ImmunologyImmune RegulationCell ProliferationTumor BiologyMyeloid Neoplasia	1988	212
Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. J R Keller, Sten Eirik W. Jacobsen, K T Sill, Proceedings of the National Academy of Sciences InflammationBone Marrow FailureGranulocyteBone Marrow ProgenitorsImmunology	1991	109
Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-<i>beta</i> 1. H Goey, J R Keller, Timothy Back, The Journal of Immunology	1989	102
Release of colony-stimulating activity from thymus-derived lymphocytes. F W Ruscetti, P. A. Chervenick Journal of Clinical Investigation Colony-stimulating ActivityLymphocyte DevelopmentGranulocyteImmunologyHematology	1975	94
Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Jennifer M. Turley, F W Ruscetti, S J Kim, PubMed Breast OncologyVitamin E SuccinateCell CycleCancer BiologyTumor Biology	1997	93
Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth Hal E. Broxmeyer, Barbara Sherry, Scott Cooper, The Journal of Immunology	1991	73

Page 1